Sun Pharma Q3 profit at Rs 2,166 cr
Sun Pharma on Tuesday reported a consolidated net profit of Rs 2,166 crore for the third quarter ended December 31, 2022.
The Mumbai-based company had posted a net profit of Rs 2,059 crore for October-December period of the previous fiscal year.
Total revenue from operations stood at Rs 11,241 crore in the period under review. It was Rs 9,863 crore in the year-ago quarter, Sun Pharmaceutical Industries said in a regulatory filing.
On February 28, 2022, the company's subsidiary Taro Pharmaceutical Industries had acquired all of the outstanding capital stock of Galderma Holdings Inc; Proactiv YK ; The Proactiv Company Corporation ; and its other assets, the drug major said.
Accordingly, results for the quarter and nine months ended December 31, 2022 are not comparable to the year-ago periods', it noted.
The company's board, which met on Tuesday, also approved an interim dividend of Rs 7.50 per share of Re 1 for 2022-23.
Shares of the company were trading 1.11 per cent down at Rs 1,039.25 apiece on the BSE.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Mumbai Indians making most of varied bowling attack in WPL: Wong
Shelar demands probe of `dubious' sale of land of Mt Mary Basilica in Mumbai
Birlas to invest Rs 1,500 cr to set up law school at BITS Pilani Mumbai campus
Mumbai's Film City, no reports of anyone getting injured: civic officials.
Mumbai: Fire breaks out on sets of TV serial `Gum Hai Kisikey Pyaar Meiin'